Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J McCormack

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 1, 1986
Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminaseC H Kim, V E Marquez, D T Mao, et al.
Investigational New Drugs|January 1, 1984
Efficacy and toxicity of 4-(2-sulfonatoethylthio)-cyclophosphamide cyclohexylamine salt (ASTA Z 7557, INN mafosfamide) after intraperitoneal administration to miceJ D Roberts, M P Hacker, R A Newman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injectionsJ Jolivet, L Landry, M F Pinard, et al.
Cancer Research|October 1, 1985
Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugsM P Hacker, A R Khokhar, D B Brown, et al.
Journal of Medicinal Chemistry|June 1, 1981
Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring sizeP S Liu, V E Marquez, J S Driscoll, et al.
Biochemical Pharmacology|May 15, 1987
Inhibition of lymphocyte nucleic acid metabolism and antibody production by trimetrexateR F Branda, J K Carney, C A Perlmutter, et al.
Journal of Medicinal Chemistry|November 1, 1986
Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosidesJ A Kelley, J S Driscoll, J J McCormack, et al.
Clinical Immunology and Immunopathology|May 1, 1996
B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1R F Branda, A L Moore, R Hong, et al.
Journal of Medicinal Chemistry|July 3, 1998
Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine)L S Jeong, G Buenger, J J McCormack, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systemsA P Krapcho, J J Landi, K J Shaw, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 1, 1986
Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminaseC H Kim, V E Marquez, D T Mao, et al.
Investigational New Drugs|January 1, 1984
Efficacy and toxicity of 4-(2-sulfonatoethylthio)-cyclophosphamide cyclohexylamine salt (ASTA Z 7557, INN mafosfamide) after intraperitoneal administration to miceJ D Roberts, M P Hacker, R A Newman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injectionsJ Jolivet, L Landry, M F Pinard, et al.
Cancer Research|October 1, 1985
Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugsM P Hacker, A R Khokhar, D B Brown, et al.
Journal of Medicinal Chemistry|June 1, 1981
Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring sizeP S Liu, V E Marquez, J S Driscoll, et al.
Biochemical Pharmacology|May 15, 1987
Inhibition of lymphocyte nucleic acid metabolism and antibody production by trimetrexateR F Branda, J K Carney, C A Perlmutter, et al.
Journal of Medicinal Chemistry|November 1, 1986
Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosidesJ A Kelley, J S Driscoll, J J McCormack, et al.
Clinical Immunology and Immunopathology|May 1, 1996
B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1R F Branda, A L Moore, R Hong, et al.
Journal of Medicinal Chemistry|July 3, 1998
Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine)L S Jeong, G Buenger, J J McCormack, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systemsA P Krapcho, J J Landi, K J Shaw, et al.
Pageof 4